Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
HKSE:00767's 9-Day RSI is ranked worse than 61.01% of 218
companies
in the Medical Diagnostics & Research industry
Industry Median: 49.22
vs HKSE:00767: 53.19
Zhong Ji Longevity Science Group (HKSE:00767) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Zhong Ji Longevity Science Group 9-Day RSI Related Terms
HKSE:00767 vs TMO, DHR, NTRA: 9-Day RSI Comparison
For the Diagnostics & Research subindustry, Zhong Ji Longevity Science Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Ji Longevity Science Group 9-Day RSI vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Zhong Ji Longevity Science Group's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Zhong Ji Longevity Science Group's 9-Day RSI falls into.
Zhong Ji Longevity Science Group (HKSE:00767) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Ji Longevity Science Group (HKSE:00767) has a 9-Day RSI of 53.19 as of Sep. 02, 2026. According to the industry distribution chart, Zhong Ji Longevity Science Group ranks #133 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 61%.
Is Zhong Ji Longevity Science Group's 9-Day RSI too high?
Zhong Ji Longevity Science Group's current 9-Day RSI is 53.19. The Medical Diagnostics & Research industry median 9-Day RSI is 49.22. Zhong Ji Longevity Science Group's value of 53.19 is 8.1% above this industry median. Based on the distribution chart, Zhong Ji Longevity Science Group ranks #133 out of 218 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Zhong Ji Longevity Science Group has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhong Ji Longevity Science Group's 9-Day RSI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Zhong Ji Longevity Science Group ranks #133 out of 218 companies for 9-Day RSI. This places Zhong Ji Longevity Science Group in the lower half of its industry. The industry median 9-Day RSI is 49.22. Zhong Ji Longevity Science Group's value of 53.19 is 8.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Diagnostics & Research company?
The median 9-Day RSI among Medical Diagnostics & Research companies is 49.22, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhong Ji Longevity Science Group's current 9-Day RSI of 53.19 is 8.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median 9-Day RSI is 49.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhong Ji Longevity Science Group's current 9-Day RSI is 53.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhong Ji Longevity Science Group stock overvalued right now?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group (HKSE:00767) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.90, compared to a current price of HK$0.48 — trading 47.2% below its estimated fair value. The current 9-Day RSI is 53.19 and 8.1% above the Medical Diagnostics & Research industry median of 49.22. Zhong Ji Longevity Science Group's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Zhong Ji Longevity Science Group (HKSE:00767), the current 9-Day RSI is 53.19 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhong Ji Longevity Science Group (HKSE:00767) Overvalued in 2026?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group stock appears to be undervalued.
The current stock price of HK$0.48 is trading 47.2% below its estimated GF Value™ of HK$0.90.
GuruFocus considers Zhong Ji Longevity Science Group to be Possible Value Trap.
Key valuation signals for HKSE:00767:
9-Day RSI: 53.19
GF Value™: HK$0.90 vs. price of HK$0.48 (47.2% below fair value)
Industry Position: 8.1% above the Medical Diagnostics & Research median (#133 of 218)
No single metric tells the full story. See the HKSE:00767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhong Ji Longevity Science Group Ltd is an investment holding company. Through its subsidiaries, it engages in Longevity science business, Money lending and Financial Advisory, Securities and other investments, and Property investment. The company generates the majority of its revenue from the Longevity Science business. The Longevity science business includes the provision of diagnostic consultation, health and medical testing and checking, distribution of cancer prevention & immunity healthcare supplements, and the sales and distribution of longevity wine.
44GF Score
Get the complete analysis for HKSE:00767
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00767 has been successfully added to your 
